THE IMPACT OF DONOR TYPE AND ABO INCOMPATIBILITY ON TRANSFUSION REQUIREMENTS AFTER NONMYELOABLATIVE HEMATOPOIETIC CELL TRANSPLANTATION (HCT)

被引：2
|
作者：
Wang, Z. [1 ]
Sorror, M. L. [1 ,2 ]
Leisenring, W. [1 ,3 ]
Schoch, G. [1 ]
Maloney, D. [1 ,2 ]
Sandmaier, B. M. [1 ,2 ]
Storb, R. [1 ,2 ]
机构：
[1] Fred Hutchinson Canc Res Ctr, Seattle, WA 98104 USA
[2] Univ Washington, Sch Med, Seattle, WA USA
[3] Univ Washington, Sch Publ Hlth & Community Med, Seattle, WA 98195 USA
来源：
BIOLOGY OF BLOOD AND MARROW TRANSPLANTATION | 2010年 / 16卷 / 02期
关键词：
D O I：
10.1016/j.bbmt.2009.12.323
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
281
引用
收藏
页码：S261 / S262
页数：2
相关论文
共 50 条
  • [31] IMPACT OF ABO INCOMPATIBILITY ON OUTCOME AFTER UNRELATED ALLOGENEIC STEM CELL TRANSPLANTATION
    Bojtarova, E.
    Ziakova, B.
    Sopko, L.
    Rimajova, V.
    Pavlikova, D.
    Batorova, A.
    Mistrik, M.
    BONE MARROW TRANSPLANTATION, 2014, 49 : S250 - S250
  • [32] IMPACT OF ABO INCOMPATIBILITY IN THE CONSUMPTION OF HEMOCOMPONENTS IN THE TRANSPLANTATION OF ALLOGENEIC HEMATOPOIETIC PROGENITORS
    Oarbeascoa, G.
    Pascual, C.
    Perez Corral, A.
    Balsalobre, P.
    Kwon, M.
    Gayoso, J.
    Serrano, D.
    Diez Martin, J. L.
    Anguita, J.
    HAEMATOLOGICA, 2017, 102 : 124 - 124
  • [33] ABO Isoagglutinin Levels in Guided Management of ABO Incompatibility in Allogeneic Hematopoietic Cell Transplantation
    Gavriilaki, Eleni
    Sakellari, Ioanna
    Konstantinou, Natassa
    Mallouri, Despina
    Bousiou, Zoi
    Masmanidou, Marianna
    Batsis, Ioannis
    Xochelli, Aliki
    Anastasiadis, Athanasios
    Gkanidou, Maria
    Anagnostopoulos, Achilles
    BONE MARROW TRANSPLANTATION, 2020, 55 (SUPPL 1) : 139 - 139
  • [34] Impact of ABO-incompatibility on hepatocellular carcinoma recurrence after living donor liver transplantation
    Kim, Seong Hoon
    Lee, Eung Chang
    Na, Byung Gon
    Park, Sang Jae
    EJSO, 2019, 45 (02): : 180 - 186
  • [35] Skin cancer after nonmyeloablative hematopoietic cell transplantation
    M Cavalier
    J A Shmalo
    M Yu
    S D Billings
    R Abonour
    R P Nelson
    Bone Marrow Transplantation, 2006, 37 : 1103 - 1108
  • [36] Skin cancer after nonmyeloablative hematopoietic cell transplantation
    Cavalier, M.
    Shmalo, J. A.
    Yu, M.
    Billings, S. D.
    Abonour, R.
    Nelson, R. P., Jr.
    BONE MARROW TRANSPLANTATION, 2006, 37 (12) : 1103 - 1108
  • [37] Effects of ABO incompatibility on the outcome of allogeneic hematopoietic stem cell transplantation
    Parkhideh, Sayeh
    Chegeni, Rouzbeh
    Mehdizadeh, Mahshid
    Roshandel, Elham
    Tavakoli, Farzaneh
    Hajifathali, Abbas
    TRANSFUSION AND APHERESIS SCIENCE, 2020, 59 (02)
  • [38] ABO-incompatibility as a risk factor for hematopoietic stem cell transplantation
    Fregatova, L
    Volkova, O
    Afanasyev, B
    BONE MARROW TRANSPLANTATION, 2002, 29 : S114 - S115
  • [39] Radiation dose determines degree of donor chimerism after nonmyeloablative hematopoietic cell transplantation.
    Kahl, C
    Mielcarek, M
    Iwata, M
    Harkey, M
    Storer, B
    Torok-Storb, B
    BLOOD, 2004, 104 (11) : 506A - 506A
  • [40] Impact of Donor Type on Outcome after Allogeneic Hematopoietic Cell Transplantation for Acute Leukemia
    Solomon, Scott R.
    Sizemore, Connie A.
    Zhang, Xu
    Brown, Stacey
    Holland, H. Kent
    Morris, Lawrence E.
    Solh, Melhem
    Bashey, Asad
    BIOLOGY OF BLOOD AND MARROW TRANSPLANTATION, 2016, 22 (10) : 1816 - 1822
12345